GB2023815A - Test means and assay for deter- mining the urea content of fluids - Google Patents
Test means and assay for deter- mining the urea content of fluids Download PDFInfo
- Publication number
- GB2023815A GB2023815A GB7919994A GB7919994A GB2023815A GB 2023815 A GB2023815 A GB 2023815A GB 7919994 A GB7919994 A GB 7919994A GB 7919994 A GB7919994 A GB 7919994A GB 2023815 A GB2023815 A GB 2023815A
- Authority
- GB
- United Kingdom
- Prior art keywords
- test means
- reagent
- quinoline
- urea
- tetrahydrobenzo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000012360 testing method Methods 0.000 title claims abstract description 49
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 title claims abstract description 48
- 239000004202 carbamide Substances 0.000 title claims abstract description 48
- 239000012530 fluid Substances 0.000 title claims abstract description 18
- 238000003556 assay Methods 0.000 title description 6
- 238000005065 mining Methods 0.000 title 1
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 59
- 238000000034 method Methods 0.000 claims abstract description 34
- 239000011159 matrix material Substances 0.000 claims abstract description 31
- 239000002253 acid Substances 0.000 claims abstract description 16
- 229940054441 o-phthalaldehyde Drugs 0.000 claims abstract description 14
- ZWLUXSQADUDCSB-UHFFFAOYSA-N phthalaldehyde Chemical group O=CC1=CC=CC=C1C=O ZWLUXSQADUDCSB-UHFFFAOYSA-N 0.000 claims abstract description 14
- 210000002966 serum Anatomy 0.000 claims abstract description 12
- 150000003839 salts Chemical class 0.000 claims abstract description 9
- WKJMQLMWPMZUQH-UHFFFAOYSA-N 1,2,3,4-tetrahydrobenzo[h]quinolin-3-ol Chemical group C1=CC2=CC=CC=C2C2=C1CC(O)CN2 WKJMQLMWPMZUQH-UHFFFAOYSA-N 0.000 claims abstract description 6
- GYYYKJPIIXLXQS-UHFFFAOYSA-N 1,2,3,4-tetrahydrobenzo[h]quinolin-3-yl acetate Chemical compound C1=CC2=CC=CC=C2C2=C1CC(OC(=O)C)CN2 GYYYKJPIIXLXQS-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000000463 material Substances 0.000 claims description 42
- MYRTYDVEIRVNKP-UHFFFAOYSA-N 1,2-Divinylbenzene Chemical compound C=CC1=CC=CC=C1C=C MYRTYDVEIRVNKP-UHFFFAOYSA-N 0.000 claims description 18
- 238000007598 dipping method Methods 0.000 claims description 14
- 239000003456 ion exchange resin Substances 0.000 claims description 12
- 229920003303 ion-exchange polymer Polymers 0.000 claims description 12
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims description 10
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 claims description 10
- 239000011347 resin Substances 0.000 claims description 7
- 229920005989 resin Polymers 0.000 claims description 7
- 230000008859 change Effects 0.000 claims description 6
- 239000012607 strong cation exchange resin Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 239000001913 cellulose Substances 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000012458 free base Substances 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 claims description 2
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 abstract description 6
- 102000004506 Blood Proteins Human genes 0.000 abstract description 3
- 108010017384 Blood Proteins Proteins 0.000 abstract description 3
- 210000002381 plasma Anatomy 0.000 abstract description 3
- 238000001556 precipitation Methods 0.000 abstract description 3
- 210000002700 urine Anatomy 0.000 abstract description 2
- 230000002452 interceptive effect Effects 0.000 abstract 1
- 239000000123 paper Substances 0.000 description 35
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- 239000000243 solution Substances 0.000 description 23
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 20
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 12
- 238000005470 impregnation Methods 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000004793 Polystyrene Substances 0.000 description 10
- 229920002223 polystyrene Polymers 0.000 description 10
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 239000003381 stabilizer Substances 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 7
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 6
- 238000004132 cross linking Methods 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- ZFXYFBGIUFBOJW-UHFFFAOYSA-N theophylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1NC=N2 ZFXYFBGIUFBOJW-UHFFFAOYSA-N 0.000 description 6
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 229920000642 polymer Polymers 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 229910052757 nitrogen Inorganic materials 0.000 description 4
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 208000037157 Azotemia Diseases 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- QSJXEFYPDANLFS-UHFFFAOYSA-N Diacetyl Chemical group CC(=O)C(C)=O QSJXEFYPDANLFS-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 229960002819 diprophylline Drugs 0.000 description 3
- KSCFJBIXMNOVSH-UHFFFAOYSA-N dyphylline Chemical compound O=C1N(C)C(=O)N(C)C2=C1N(CC(O)CO)C=N2 KSCFJBIXMNOVSH-UHFFFAOYSA-N 0.000 description 3
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 3
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- -1 polypropylene Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000001055 reflectance spectroscopy Methods 0.000 description 3
- 229960000278 theophylline Drugs 0.000 description 3
- 208000009852 uremia Diseases 0.000 description 3
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000012445 acidic reagent Substances 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- MEWHPEMEOXZHNL-UHFFFAOYSA-N benzo[h]quinoline;hydrochloride Chemical compound Cl.C1=CN=C2C3=CC=CC=C3C=CC2=C1 MEWHPEMEOXZHNL-UHFFFAOYSA-N 0.000 description 2
- 239000013060 biological fluid Substances 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 229920001429 chelating resin Polymers 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000005342 ion exchange Methods 0.000 description 2
- 208000017169 kidney disease Diseases 0.000 description 2
- 230000003907 kidney function Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- INDBQLZJXZLFIT-UHFFFAOYSA-N primaquine Chemical compound N1=CC=CC2=CC(OC)=CC(NC(C)CCCN)=C21 INDBQLZJXZLFIT-UHFFFAOYSA-N 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- JDCCCHBBXRQRGU-UHFFFAOYSA-N 5-phenylpenta-2,4-dienenitrile Chemical compound N#CC=CC=CC1=CC=CC=C1 JDCCCHBBXRQRGU-UHFFFAOYSA-N 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 201000005569 Gout Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- NULAJYZBOLVQPQ-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine Chemical compound C1=CC=C2C(NCCN)=CC=CC2=C1 NULAJYZBOLVQPQ-UHFFFAOYSA-N 0.000 description 1
- MZNYWPRCVDMOJG-UHFFFAOYSA-N N-(1-naphthyl)ethylenediamine dihydrochloride Chemical compound [Cl-].[Cl-].C1=CC=C2C([NH2+]CC[NH3+])=CC=CC2=C1 MZNYWPRCVDMOJG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 206010037596 Pyelonephritis Diseases 0.000 description 1
- 206010038422 Renal cortical necrosis Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- QYKIQEUNHZKYBP-UHFFFAOYSA-N Vinyl ether Chemical compound C=COC=C QYKIQEUNHZKYBP-UHFFFAOYSA-N 0.000 description 1
- UVJZGFKZGQSKDV-OUKQBFOZSA-N [(e)-1,3-diphenylprop-2-enyl] acetate Chemical compound C=1C=CC=CC=1C(OC(=O)C)\C=C\C1=CC=CC=C1 UVJZGFKZGQSKDV-OUKQBFOZSA-N 0.000 description 1
- ICSCRHYRHAFLQG-UHFFFAOYSA-N [N].[N].NC(N)=O.NC(N)=O Chemical compound [N].[N].NC(N)=O.NC(N)=O ICSCRHYRHAFLQG-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 235000012501 ammonium carbonate Nutrition 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- MIAUJDCQDVWHEV-UHFFFAOYSA-N benzene-1,2-disulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1S(O)(=O)=O MIAUJDCQDVWHEV-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- 229940092714 benzenesulfonic acid Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000005341 cation exchange Methods 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000007398 colorimetric assay Methods 0.000 description 1
- 239000007822 coupling agent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000005430 kidney cortex necrosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 230000036210 malignancy Effects 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 201000009925 nephrosclerosis Diseases 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 229920000172 poly(styrenesulfonic acid) Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229940005642 polystyrene sulfonic acid Drugs 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 229960005179 primaquine Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000022558 protein metabolic process Effects 0.000 description 1
- 210000005084 renal tissue Anatomy 0.000 description 1
- 206010038534 renal tuberculosis Diseases 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 238000012799 strong cation exchange Methods 0.000 description 1
- 229920003048 styrene butadiene rubber Polymers 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000002601 urease inhibitor Substances 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000002759 woven fabric Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/62—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving urea
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N31/00—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods
- G01N31/22—Investigating or analysing non-biological materials by the use of the chemical methods specified in the subgroup; Apparatus specially adapted for such methods using chemical indicators
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Test means, method for making same and method for assaying the urea content of fluids such as blood serum, plasma, urine and spinal fluid are disclosed. The preferred method for making the test means involves a three stage application of reagents separated from each other on an acid modified carrier matrix. One reagent is o- phthalaldehyde and the other reagent is 3-hydroxy-1,2,3,4-tetrahydrobenzo[h] quinoline, 3-acetoxy-1,2,3,4- tetrahydrobenzo[h]quinoline or their dihydrochloride salts. Stability of the reagents is achieved and precipitation of serum proteins is avoided. Moreover, the interfering color due to the presence of bilirubin is minimized when the urea content of serum is determined.
Description
SPECIFICATION
Test means and assay for determining the urea content of fluids.
BACKGROUND OF THE INVENTION 1. Field of the Invention
This invention relates to assaying the urea content of fluids and aqueous solutions and, more particularly, to test means and methods for improving the stability of colorimetric assays for the rapid and accurate determination of urea.
2. Description ofthe Prior Art Urea is a chief end product of protein metabolism in the human body. Urea concentration in the blood accordingly provides an indicator of kidney function. Elevation of the urea concentration in blood signifies inadequate kidney function. Since toxic substances are retained in the blood in rough proportion to urea level, a high nonprotein nitrogen or blood-urea-nitrogen level is a matter of concern to a physician.
One of the commonest causes of high blood urea values (uremia) is renal disease which may be either acute or chronic. Any of the inflammatory, degenerative, congenital or neoplastic ills that affect the kidney can cause uremia, and the degree of uremia provides a rough index to the severity of the existing condition.
In practice, the concentration of urea in blood is normally expressed in terms of blood-urea-nitrogen (BUN). This BUN value represents the amount of nitrogen present as urea and is approximately one half of the total urea value. When either the urea or nitrogen value has been determined, the other value can be calculated therefrom.
The normal range of BUN values in individuals varies from between 5 and 20 milligram percent (mg%). No significance is ordinarily attached to the lower values. However, elevations in BUN values generally indicate the presence of an abnormal condition. The most common cause of increased blood-urea-nitrogen is inadequate excretion, usually due to a kidney disease or urinary obstruction. For example, in acute nephritis the BUN level may vary from 25 mg ,Oto as high as 160 mg%. Elevated urea retention also occurs in extensive parenchymatous destruction of kidney tissue, as in pyelonephritis, advanced nephrosclerosis, renal tuberculosis, renal cortical necrosis, renal malignancy, renal suppuration or chronic gout. Although
BUN values can rise to as high as 400 mg%, they usually do not exceed 200 mg%.
A need thus exists in the medical field today for a rapid and accurate analytical technique for determining
BUN. In the past, cumbersome wet chemical methods have been used to perform such analysis. Other methods, such as conductivity methods, spectrophotometric techniques and colorimetric techniques have also been utilized. While these methods are generally accurate, the techniques tend to be somewhat time consuming and can require careful interpretation.
In perhaps the most commonly used method for determination of urea in biological fluids, urea is hydrolyzed to ammonium carbonate by means of the enzyme urease in the presence of a buffer solution. The amount of ammonia liberated is determined colorimetrically. This first method is very specific and sensitive, but has the drawback of urease inhibition and inactivation, the problem of reagent stability and a further drawback in that the method measures endogenous ammonia. Another procedure utilizes hydrolysis with urease and requires special apparatus not always available in the routine laboratory. Yet another procedure employs the direct colorimetric reaction of urea in a protein free filtrate with an organic reagent such as diacetyl monoxine.The diacetyl reaction has the disadvantage that the colour produced is unstable, the fact that colours are developed at about 95"C and that the volatile diacetyl has an odor which is unpleasant to at least some individuals.
In U.S. Letters Patent No. 4,074,972, assigned to American Monitor Corporation, a liquid assay for urea is disclosed which involves a reaction between a sample of biological fluid and an acidic reagent solution of o-phthalaldehyde and 8-(4-amino-1-methyl butyl amino)-6-methoxy-quinoline. There is neither a teaching nor a suggestion of incorporating the reagent solution into a test means, such as a carrier matrix, let alone a strong cation exchange resin loaded carrier matrix which is in its acid form. Moreover, this patent does not disclose any method of overcoming the stability problem which occurs when the reagents of the acidic reagent solution are combined.Another problem of the disclosed assay is the fact that determinations must be made at wavelengths in the range of 470 to 540 nanometers which is close to the blank color absorption maximum resulting in the likelihood of reflectance spectroscopy measurement errors.
In the industrial area, urea is an important addition to process fluids such as plating baths, and a quick means to determine the concentration of urea therein is of great value. Urea itself is used as a fertilizer, and a quick means for assaying this material is important as a control measure in its production and use.
Accordingly, for both medical and industrial applications there is a need for assaying the urea content of fluids which can be run quickly without highly specialized equipment or trained technicians to operate such equipment.
Summary of the Invention
An object of the present invention is to provide test means for determining the urea content of fluids wherein stability of reagents utilized to make the test means is achieved,
An other object of the present invention is to minimize interferences due to serum turbidity and the presence of bilirubin when assaying the urea content of blood serum.
Still another object of the present invention is to provide test means having high specificity and sensitivity for determining urea in fluids over a range of concentrations.
Yet another object of the present invention is to provide colorimetric test means capable of detecting urea when the quantity of fluid to be assayed is limited.
Afurtherobjectofthe present invention isto provide a BUN assaywhich can be run quicklywithoutthe need for highly specialized equipment.
In accordance with the present invention test means for detecting urea present in a test fluid comprises an acid modified carrier member incorporating reagents separated from each other. One reagent is o-phthalaldehyde, and the other reagent is 3-hydroxy-1,2,3,4-tetrahydrobenzo[h] quinoline, 3-acetoxy1 ,2,3,44etrahydrobenzo[h]quinoline, or their dihydrochloride salts. Advantageously, the reagents are separated from each other by a polymeric material.
The test means can be used by momentarily dipping it into a test sample or otherwise introducing test sample onto the carrier matrix, and observing any detectable color change which results.
Description of the PreferredEmbodirnents For the purpose of this application the term "fluids" shall be understood to refer to body fluids such as blood serum, blood plasma, urine, spinal fluid and, in addition, shall refer to aqueous solutions containing urea. Although the most preferred application of the test means and method of this invention is to body fluids, such as blood serum, it should be understood that the test means and method can be applied to industrial fluids as well.
In accordance with the present invention a unique reagent strip is prepared by incorporating with a carrier matrix the reagents herein described suitably separated thereon, e.g., by a polymeric barrier. The expression "carrier matrix" refers to bibulous and nonbibulous matrices which are insoluble in and maintain their structural integrity when exposed to water or other physiological fluids. Suitable bibulous matrices which can be used include paper, cellulose, wood, synthetic resin fleeces, woven and nonwoven fabrics and the like. Nonbibulous matrices include glass fiber and organo-plastic materials, such as polypropylene and the like. The matrix can advantageously be affixed to an insoluble support member such as organo-plastic strip, e.g., polystyrene, by suitable means such as double faced adhesive tape, for ease of use.
The reagents incorporated with the carrier matrix react with urea under acid conditions to produce a chromogen which absorbs light above about 550 nanometers and normally between about 550 and about 700 nanometers. Quantitation can be achieved by monitoring the change in reflectance at about 620 nanometers after appliction of or contact with sample.
In order to achieve the desired acidity for the conditions of the assay, it has been found necessary to modify or impregnate the carrier matrix with an acid material. One method of preparing the acid modified carrier matrix involves impregnatins the carrier matrix with acid materials such as benzenesulfonic acid, benezenedisulfonic acid, polystyrenesulfonic acid of the like in an amount between about 5 and about 10 gram percent.
An alternate method of preparing the acid modified carrier matrix involves loading the carrier matrix with strong cation exchange resins, preferably in their acid form. Ion exchange resin loaded carrier matrices containing Amberlite IR 120 (Rohm ti Haas, Philadephia, Pennsylvania) or Dowex 50 (Dow Chemical Co.,
Midland, Mich) are particularly preferred as sulfonic acid modified carrier materials, especially when serum is used. These particular ion exchange resins are sulfonic acid modified polystyrenes crosslinked with various amounts of divinylbenzene. Each carrier matrix is loaded with between about 25 and about 50 percent by weight of ion exchange resin and preferably between about 35 and about 50 percent by weight.
Two reagents are used to prepare the test means. One reagent is o-phthalaldehyde and the other reagent is 3-hydroxy-l ,2,3,4-tetrahydrobenzo[h]quinoline, 3-acetoxy-1 ,2,3,4-tetrahydrobenzo[h]quinoline or their dihydrochloride salts. 3-hydroxy-1 ,2,3,4-tetrahydrobenzo[h]quinoline is preferred.
While in accordance with the present invention the reagents must be applied to the carrier matrix separately, the order of application cf the reagents is immaterial. Thus, any reagent can be applied first. The sulfonic acid material can be applied to the carrier matrix either simuitaneously with the first reagent or an ion exchange resin loaded carrier matrix can be used.
In the preferred method the first stage thus comprises application of at least one reagent to the carrier matrix. The second stage normally comprises applying polymer to the carrier matrix, the polymer being present in a solvent that does not dissolve either the first reagent or the sulfonic acid material. Polymers such as methylcellulose, cellulose acetate, polyethylene oxide, styrene-butadiene copolymer, styrene-isoprene copolymer, polystyrene and styrene-acrylo-nitrile copolymer can be used. Finally, the third or final stage comprises applying the other reagent to the carrier matrix, the reagent being present in a solvent which does not dissolved the polymeric materia applied in the second stage. Normally, the reagent strip is permitted to dry between each stage.
Suitable solvents for use with o-phthalaldehyde include water, methanol, acetone and hexane. Water,
methanol or a mixture thereof is the preferred solvent if the reagent o-phthalaldehyde is applied in the first stage. Acetone or hexane is the pref erred solvent if the reagent o-phthalalhehyde is applied in the third stage. With respect to the polymers suitable solvent include chloroform, acetone, benzene, toluene and the like. Suitable solvents for the other reagent include water, methanol, and methanol and acetone mixtures.
Water is again the preferred solvent when the reagent is applied in the first stage and either methanol or a methanoi-acetone mixture is the preferred solvent when the reagent is applied in the third stage.
The reagents can be used in various concentrations. Normally, o-phthalaldehyde is present in the amount of from about 300 milligram percent (mg%) to 800 mg% and preferably is present in an amount between about 500 mg% and 600 mg%. The otner reagent is normally present in an amount between about 200 mg% and about 500 mg% when a dihydrochloride salt is employed and in the amount of from about 600 mg% to about 1200 mg% when the free base is used. The concentrations of the polymeric material are not critical provided an amount between 0.5 gram percent (g%) and about 5 g% is used. Preferably, the polymeric material should be present in an amount between about 1 g% and 3 g%.
While the preferred method of preparing the test means is by three stage impregnation followed by drying, the test means of the present invention can also be made by other suitable techniques, such as printing on one or more sides of a matrix or suitably applying separate reagents to opposite sides of a substrate or matrix.
Test means according to the present invention is advantageously used by momentarily dipping it in a test sample or by otherwise introducing a test sample onto the carrier matrix, and observing any detectable colour change which results.
Example 1
The preparation of test means in the form of a test device will now be described. Hydrochloric acid (10-20%) prewashed cation exchange loaded filter paper, SA-2, obtained from Reeve Angel, Clifton, New
Jersey, having an exchange capacity of about 4 milliequivalents per gram of dry resin was impregnated with the following solutions in three stages after being rinsed with dionized water and dried. The SAZ paper is a paper containing Amberlite IR120 ion exchange resin sulfonated to give ion exchange properties. The resin is supplied in the sodium form and the paper contains between 45 and 50 percent of resin.
Firstimpregnation Stage
The filter paper was impregnated by dipping into a solution containing the following materials in the amounts indicated.
Material Amount water 100 milliliters (ml) maleic anhydride-methyl 100 milligrams (mg)
vinyl ether copolmer
(stabilizer) boric acid (color stabilizer) 2.5 grams (g) o-phthalaldehyde 300 mg 7 (2,3-dihydroxypropyl)- lOg theophylline (stabilizer)
Following impregnation, the paper was dried at60 Cfor30 minutes.
Second Impregnation Stage
The dried impregnated paper from the first stage was then impregnated by dipping into a solution containing the following materials in the amounts indicated:
Material Amount toluene 100 ml polystyrene pellets (Styron, 2 g
Dow Chemical Co., Midland,
Mich.)
Third Impregnation Stage
The dried impregnated paper from the second stage was then impregnated by dipping into a solution containing the following materials in the amounts indicated. Materials (1 ) and (4) were dissolved first, materials (2) and (3) were separately dissolved and then added to materials (1) and (4) to form the solution.
Material Amount (1) methanol 30 ml (2) acetone 70 ml (3) hydroxypropyl celluose 0.5 g (Stabilizer) (4) 3-hyd roxy-1 ,2,3,4-tetrahydro- 300 mg benzo[h]quinoline hydrochloride
The paper was then dried at 600C for 10 minutes and applied to a polystyrene substrate by means of double faced adhesive tape. The polystyrene substrate provides a suitable handle with which to dip the resulting reagent impregnated paper test device into a solution for purposes of assaying the urea content of the solution.
The color intensity of urea nitrogen reagent strips to various urea concentrations is shown in the following table.
One part of a serum sample containing the indicated amount of urea nitrogen is diluted with two parts of water and 0.030 ml are applied to the surface of a test device prepared as in Example 1. After incubating at 37"C for one minute, the reflectance of the reagent strip is measured at 620 nanometers (nm) relative to a barium sulfate, white reflecting surface.
Table 1
Urea Nitrogen Urea Nitrogen
Concentration %Reflectance Concentration %Reflectance mg% mg% 0 75 50 30 5 62 60 27 10 54 70 25 20 44 90 21 30 38 120 18 40 33 150 15
Example II The preparation of another test means will now be described. Filter paper loaded at 40% by weight with
Dowex 50W, supplied in its acid form, 8% crosslinked with divinylbenzene (Dow Chemical Co., Midland,
Michigan) was impreganted with the following solutions in three stages.
Firstimpregnation Stage
The filter paper was impregnated by dipping into a solution containing the following materials in the amounts indicated.
Material Amount water 100 millilitres (ml) polyethylene oxide 50 milligrams (mg) o-phthalaldehyde 300 mg 7-(2,3-dihydroxypropyl)- lOg theophylline (stabilizer) boric acid 2.5 g
Following impregnation, the paperwas dried at 600C for 30 minutes.
Second Impregnation Stage
The dried impregnated paper from the first stage was then impregnated by dipping into a solution contain the following materials in the amounts indicated:
Material Amount toluene 100 ml styrene-acrylonitril 2g
copolymer
Following impregnation with the styrene copolymer, the paper was dried at 60"C for 15 minutes.
Third lmpregnation Stage
The dried impregnated paper from the second stage was then impregnated by dipping into a solution containing the following materials in the amounts indicated. Materials (1) and (4) were dissolved first; materials (2) and (3) were separately dissolved and then added to materials (1) and (4) to form the solution.
Material Amount (1) methanol 30 ml (2) acetone 70 ml (3) hydroxypropyl cellulose 0.5 g (4) 3-acetoxy-1,2,3,4-tetrahydro- 300 mg benzo[h]quinoline hydrochloride
The paper was then dired at 608C for 10 minutes and applied to a polystyrene substrate by means of double faced adhesive tape. The polystyrene substrate provides a suitable handle with which to dip the resulting reagent impregnated paper test device into a solution for purposes of assaying the urea content of the solution.
Other test means were prepared by the same procedure of this Example II using Dowex 50W which was 2% crosslinked with divinylbenzene and 16% crosslinked with divinylbenzene. It was found that intensity of color production dipped in a sample of urea could be controlled by varying the amount of crosslinking.
Intensity varied inversely with the degree of crosslinking.
The rate of color formation of urea nitrogen reagent strips prepared with carriers containing ion exchange resins of varied divinylbenzene (DVE;) crosslinking is shown in the following table.
Reagent strips were prepared as in Example II with ion exchange resin loaded paper containing Dowex 50 resins of 2%, 8% and 16% divinylbenzene crosslinking. Urea samples were then diluted, incubated for one minute at 37"C and measured on a reflectometer as in Table 1.
Table 2
Reflectance Readings at Various Urea Concentrations and DVB Crosslinking (Reflectance readings and color intensity vary inversely)
Urea Nitrogen %DVB Crosslinking
Concentration
mg% 2 8 16
20 37 44 66
40 27 33 56
60 21 27 50
The rate of color formation of urea nitrogen reagent strips prepared with carriers loaded having varied amounts of ion exchange resin is illustrated in the following table.
Reagent strips were prepared as in Example 1 with ion exchange resin loaded paper containing 25%, 35% and 50% by weight of an 8% divinylbenzene crosslinked ion exchange resin. Urea samples were diluted, incubated for one minute at 370C and measured on a reflectormeter as in Table 1.
Table 3
Reflectance Readings at Various Urea Concentration and Resin Loadings
mg% Urea % Resin Loading
Nitrogen
Concentration 25 35 50
20 58 51 44
40 48 40 33
60 42 33 27
Example 111 Using ion exchange paper as described in Example II a test device was prepared by the following three
stage procedure: First Impregnation Stage
The paper was impregnated by dipping into a solution containing the following materials in the amounts indicated.
Materials Amount water 25 ml polyethylene oxide 100 mg 7-(2,3 dihydroxypropyl)- lOg theophylline ethylenedinitrilotetra- 1.5 g
acetic acid, dipotassium salt sodium lauryl sulfate 100 mg methanol 75 ml glycerol 0.2 ml boric acid 4.5 g o-phthalaldehyde 600 mg
Following impregnation the paper was dried at 500C for 20 minutes.
Second Impregnation Stage
Materials Amount toluene 100 ml polystyrene pellets 39 Following impregnation with the styrene polymer the paper was dried at 50'for 10 minutes.
Third lmpregnation Stage
The dried impregnated paper from the second stage was then impregnated by dipping into a solution containing the following materials in the amounts indicated. Materials (2), (3) and (4) were separately combined and then material (1) was added to form the solution.
Materials Amount
(1) methanol 25 ml
(2) acetone 75 ml
(3) hydroxypropyl cellulose 0.75 g
(4) 3-hydroxy-1,2,3,4-tetra- 900 mg hydrobenzo[h]quinoline The paper was dried for 5 minutes at 50"C. The resulting test device can be used with blood serum or
plasma which has not been diluted, as required in the case of the test device of Example I and II, for concentrations up to 70 mg% urea nitrogen.
It will also be understood that the use of the stabilizer hydroxypropyl cellulose is not critical to the present invention. It will be further understood that a stabilizer such as caffeine can be substituted for dyphylline employed in the following example. It has been found that dyphylline or its substitute should be used in an amount greater than 5 gram percent.
Example IV For comparison purposes, another test device is prepared by the following procedure.
First Stage
Whatman 3MM filter paper is acid modified by dipping it into a solution containing the following materials
in the amounts indicated.
Material Amount water 100 ml benzenedisulfonic acid lOg N-naphthylethylenediamine 400 mg
dihydrochloride dyphylline lOg maleicanhydride-methyl 0.19 vinyl ether copolymer
(stabilizer)
Following impregnation the paper is dried at 60"C for 20 minutes.
Second Stage
The dried impregnated paper from the first stage is then impregnated by dipping into a solution containing the following materials in the amount indicated:
Material Amount polyethylene oxide 1g chloroform 70 ml acetone 30 ml
The paper is then dried at 60"C for 20 minutes.
Third Stage
The dried impregnated paper from the second stage is then impregnated by dipping into a solution containing the following materials in the amounts indicated:
Material Amount hexane 100 ml o-phthalaldehyde 300 mg
The paper is then dried as before ac 60 C for 20 minutes. The resulting dried impregnated paper is then applied to a polystyrene substrate using double faced adhesive tape. The resulting reagent strip can be used to quantitate deproteinized samples. Undesirable precipitation occurs when attempts are made to quantitate samples containing protein. This fact emphasizes the significance of the discovery which has been made.
From the foregoing, it will be seen that this invention is well adapted to attain all of the ends and objects hereinabove set forth, together with other advantages which are obvious and which are inherent to the system. Three specific problems are solved by the preparation of reagent strips according to the present invention.
First, under the usual acid conditions of the assay serum proteins normally precipitate and interfere with the development of chromogen. The present invention eliminates the precipitation of serum proteins while providing a suitable acid matrix by using a strong cation exchange loaded paper.
Secondly, the reagents utilized are normally unstable. The present invention provides a method for incorporating the reagents on a paper matrix in a format such that the reagents are stabilized.
The third problem solved in accordance with the present invention is the minimization of error in reflectance spectroscopy measurements when determining the urea content of blood serum. The present invention utilizes a coupling agent which produces a chromogen detectable at wavelengths well above 550 nanometers, thereby overcoming the problem caused by a yellow blank reaction occurring on the strips and the interferring color caused by bilirubin and/orturbidity in serum, observed by absorption or reflectance spectroscopy. The use of 3-hydroxy-1 ,2,3,4-tetrahydrnbenzoth]quinoline or its dihyrochioride salt minimizes the blank reaction which occurs.In contrast, when primaquine diphosphate [8-(4-amino-1methylbutylamino)-6-methoxyquinoline] or N-naphthylethylenediamine dihydrochloride is used the chromogen produced develops color which must be measured at wavelengths near the absorption maximum of the blank reaction. Therefore, use of 3-hydroxy-1 ,2,3,4-tetrahydrobenzo[h]quinoline or its dihydrochloride salt allows measurements to be made at wavelengths where color, due to the blank reaction, is minimal.
Moreover, the present invention incorporates all reagents into a single matrix without the use of corrosive liquid reagents.
Although the present invention has great importance in the early detection of physiological disorder by determining the urea content of body fluids, as indicated herein it also has important application in the accurate determination of urea in industrial process fluids where urea concentration must be controlled within defined limits. Means for the determination of urea fluids, whether industrial or physiological, is of greatest value if the test means is conveniently rapid, reliable and simple enough for the technician to learn with ease. Moreover, in the case of medial disgnosis, the test means must be accurate enough to reflect variations in a subjects condition. These objectives are achieved using the present invention.
Obviously, many other modificatic ns and variations of the invention as hereinabove set forth may be made without departing from the spirit and scope thereof.
Claims (13)
1. Test means for detecting urea which comprises a strong cation exchange resin loaded carrier matrix which is in its acid form having incor Dorated therewith in separated relation the reagent o-phthalaldehyde and a reagent from the group consis1 ing of 3-hydroxy-1 ,2,3,4-tetrahydrobenzo[h]quinoline, 3-acetoxy- 1,2,3,4-tetrahydrobenzo[h]quinoline and their dihydrochloride salts.
2. The test means of claim 1 in which 3-acetoxy-1 ,2,3,4-tetrahydrobenzo[h]quinoline is present.
3. The test means of claim 1 in which 3-hydroxy-1 ,2,3,4-tetra hydrobenzo[h]quinoline is present.
4. The test means of claim 2 or 3 n which the reagent o-phthalaldehyde is present in an amount of from about 300 milligram percent to above 800 milligram percent and the other reagent is present in an amount of from about 200 milligram percent to about 500 milligram percent when dihydrochloride salt is used and in an amount of from about 600 milligram percent to above 1200 milligram percent when free base is used.
5. The test means of claim 1 in w ich the reagents are separated from each other by a polymeric material.
6. The test means of claim 1 whe ein the carrier matrix is bibulous cellulose paper matrix.
7. The test means of claim 6 in w iich the carrier matrix is loaded with from about 25 to about 50 percent by weight of ion exchange resin.
8. The test means of claim 7 whe ein the ion exchange resin is a resin having between about 2 and about 16 percent divinylbenzene crosslinki ig.
9. A method for detecting urea in a liquid test sample which comprises momentarily dipping the test means of claim 1 in the test sample e nd observing any detectable color change which results.
10. The method of claim 9 in whi ,h the test sample is blood serum.
11. The method of claim 9 in which the color change is observed by monitoring a change in reflectance above about 550 nanometers.
12. A method for preparing test means for assaying the urea content of fluids, which method comprises incorporating with a strong cation exchange resin loaded carrier matrix which is in its acid form first and second reagents separated from each other by a polymeric material, said first reagent comprising o-phthalaldehyde, and said second reagent comprising 3-hyd roxy-l ,2,3,4-tetrahydrobenzo [h]quinoline, 3-acetoxy-1, 2,3,4-tetrahydrobenzo[h]quinoline, or their dihydrochloride salts.
13. A test means as claimed in Claim 1 substantially as described in any one of Examples I, II and Ill.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91558778A | 1978-06-15 | 1978-06-15 | |
US06/039,113 US4215995A (en) | 1979-05-15 | 1979-05-15 | Test means and assay for determining the urea content of fluids |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2023815A true GB2023815A (en) | 1980-01-03 |
GB2023815B GB2023815B (en) | 1982-12-15 |
Family
ID=26715824
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB7919994A Expired GB2023815B (en) | 1978-06-15 | 1979-06-08 | Test means and assay for determining the urea content of fluids |
Country Status (9)
Country | Link |
---|---|
AU (1) | AU521386B2 (en) |
CA (1) | CA1108514A (en) |
DE (1) | DE2922748C2 (en) |
ES (1) | ES481516A1 (en) |
FR (1) | FR2434393A1 (en) |
GB (1) | GB2023815B (en) |
IT (1) | IT1116892B (en) |
NL (1) | NL187995C (en) |
SE (1) | SE444085B (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0497385A1 (en) * | 1988-03-03 | 1992-08-05 | Miles Italiana SpA | New indicator compounds, method of their preparation and use of those compounds in an iron assay system |
US8198073B2 (en) | 2006-01-19 | 2012-06-12 | Lattec I/S | Dry stick device and method for determining an analyte in a sample |
AU2007207241B2 (en) * | 2006-01-19 | 2012-07-26 | Lattec I/S | A novel dry stick device construction and method for determining an analyte in a sample using said dry stick device |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL296257A (en) * | 1962-08-06 | |||
US3449080A (en) * | 1964-10-29 | 1969-06-10 | Johnson & Johnson | Device for determining sodium or chloride concentration in body fluids |
US3723064A (en) * | 1971-07-26 | 1973-03-27 | L Liotta | Method and device for determining the concentration of a material in a liquid |
US3901657A (en) * | 1974-04-29 | 1975-08-26 | Sun Scient Inc | Device for testing solutions and body fluids |
US3890099A (en) * | 1974-07-05 | 1975-06-17 | David H Jung | Colorimetric assay for urea |
DE2436598C2 (en) * | 1974-07-30 | 1983-04-07 | Boehringer Mannheim Gmbh, 6800 Mannheim | Stable test strip for the detection of ingredients in liquids |
US4074972A (en) * | 1976-11-10 | 1978-02-21 | American Monitor Corporation | Urea assay |
-
1979
- 1979-06-05 CA CA329,125A patent/CA1108514A/en not_active Expired
- 1979-06-05 DE DE2922748A patent/DE2922748C2/en not_active Expired
- 1979-06-07 AU AU47865/79A patent/AU521386B2/en not_active Ceased
- 1979-06-08 GB GB7919994A patent/GB2023815B/en not_active Expired
- 1979-06-12 IT IT49382/79A patent/IT1116892B/en active
- 1979-06-13 ES ES481516A patent/ES481516A1/en not_active Expired
- 1979-06-14 FR FR7915281A patent/FR2434393A1/en active Granted
- 1979-06-14 SE SE7905266A patent/SE444085B/en not_active IP Right Cessation
- 1979-06-15 NL NLAANVRAGE7904720,A patent/NL187995C/en not_active IP Right Cessation
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0497385A1 (en) * | 1988-03-03 | 1992-08-05 | Miles Italiana SpA | New indicator compounds, method of their preparation and use of those compounds in an iron assay system |
US8198073B2 (en) | 2006-01-19 | 2012-06-12 | Lattec I/S | Dry stick device and method for determining an analyte in a sample |
EP1982183B1 (en) * | 2006-01-19 | 2012-06-27 | Lattec I/S | Dry stick device and method for determining an analyte in a sample |
AU2007207241B2 (en) * | 2006-01-19 | 2012-07-26 | Lattec I/S | A novel dry stick device construction and method for determining an analyte in a sample using said dry stick device |
AU2007207242B2 (en) * | 2006-01-19 | 2012-08-02 | Lattec I/S | Dry stick device and method for determining an analyte in a sample |
US8460863B2 (en) | 2006-01-19 | 2013-06-11 | Lattec I/S | Dry stick device and method for determining an analyte in a sample |
Also Published As
Publication number | Publication date |
---|---|
FR2434393A1 (en) | 1980-03-21 |
DE2922748A1 (en) | 1979-12-20 |
ES481516A1 (en) | 1980-01-16 |
NL187995C (en) | 1992-03-02 |
NL187995B (en) | 1991-10-01 |
DE2922748C2 (en) | 1984-03-22 |
IT7949382A0 (en) | 1979-06-12 |
SE7905266L (en) | 1979-12-16 |
IT1116892B (en) | 1986-02-10 |
FR2434393B1 (en) | 1984-03-16 |
AU4786579A (en) | 1980-11-20 |
GB2023815B (en) | 1982-12-15 |
NL7904720A (en) | 1979-12-18 |
SE444085B (en) | 1986-03-17 |
CA1108514A (en) | 1981-09-08 |
AU521386B2 (en) | 1982-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0101799B1 (en) | High glucose-determining analytical element | |
EP2382322B1 (en) | Device and method for detection of humidity-compromised urine test strips | |
CA1301604C (en) | Minimum procedure system for the determination of analytes | |
US3598704A (en) | Diagnostic device for various sugars | |
JPH022103B2 (en) | ||
US5326707A (en) | Composition and device for urinary protein assay and method of using the same | |
US4215995A (en) | Test means and assay for determining the urea content of fluids | |
US4291121A (en) | Bilirubin-resistant determination of uric acid and cholesterol | |
AU754237B2 (en) | Uric acid assay device with stabilized uricase reagent composition | |
CA1108514A (en) | Test means and assay for determining the urea content of fluids | |
US5906916A (en) | Peroxide test strip | |
US6753159B1 (en) | Uric acid assay device with stabilized uricase reagent composition | |
GB2049180A (en) | Bilirubin-resistant determination of uric acid | |
JPS621220B2 (en) | ||
NO742419L (en) | ||
US11428639B2 (en) | Device and method for detection of humidity-compromised urine test strips | |
FI81451C (en) | Method, test compositions and test devices for semi-quantitative determination of glucose in an aqueous test sample | |
JPH034799A (en) | Testing paper for determining alcohol | |
US7166234B1 (en) | Dialdehyde assay | |
EP1160569A2 (en) | Assay for aldehyde content |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19930608 |